Skip to content

A comparative study on the efficacy of intermittent theta burst repetitive transcranial magnetic stimulation of the cerebellum and suprahyoid muscle group in the treatment of post-stroke dysphagia

A comparative study on the efficacy of intermittent theta burst repetitive transcranial magnetic stimulation of the cerebellum and suprahyoid muscle group in the treatment of post-stroke dysphagia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110976
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-05-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia after stroke

Interventions

Conventional group:The treatment is routine swallowing rehabilitation training, which includes four core modules: The first is oral-facial function and sensory training using ice-acid stimulation and
Second, through Shaker training and glottic closure exercises, the functions of laryngeal elevation and glottic closure are strengthened. The third is to guide the compensation of eating postures and
Cerebellum group:The treatment involves cerebellar iTBS therapy and conventional swallowing rehabilitation training. The cerebellar stimulation target is based on the occipital protrusion as a bony ma
Combined treatment group:The treatment included conventional swallowing rehabilitation training and iTBS therapy for the cerebellum and suprhyoid muscle group. The positioning of the suprhyoid muscle

Sponsors

The Affiliated Taian City Central Hospital of Qingdao University, 271000 Taian, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stroke according to the above diagnostic criteria for stroke; 2. First-time stroke patients with a disease course of more than 14 days. 3. Swallowing X-ray fluoroscopy (VFSS) confirmed the presence of dysphagia. 4. The patient's vital signs were stable, the patient was conscious, and there were no obvious contraindications. The patient could cooperate with the treatment. 5. The patient and their family agree to participate in the test and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe mental disorders and cognitive impairments; 2. Patients with metal stents implanted in the brain or heart or pacemakers implanted in the heart 3. Those with severe internal diseases, such as pharyngeal or thyroid ulcers, lung infections, tumors, etc. 4. Patients with high risk of thrombosis and untreated hypertension 5. Those with vertigo 6. Patients whose condition changes during treatment and are not suitable for continued treatment.

Design outcomes

Primary

MeasureTime frame
Oral transport time;Palatopharyngeal closure time;Hyoid bone displacement time;Upper esophageal sphincter opening time;

Secondary

MeasureTime frame
Penetration-aspiration scale;Functional Oral Intake Scale;

Countries

China

Contacts

Public ContactHuimin Jia

The Affiliated Taian City Central Hospital of Qingdao University, 271000 Taian, China

363403195@qq.com+86 151 6388 3658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026